As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have passed. Looking back at the summer doldrums, the market, so far in fall, has been ‘exciting.’ The increased volatility we have been witnessing in the health sector, finance sector and even a bit in the consumer staples sector has all been noteworthy and judging by all the recent buying posts I have been reading it looks like many of us are taking advantage of these near term dips in some otherwise solid dividend paying stocks. With a new month upon us it’s time, once again, for me to look at my portfolio holdings and watch lists and figure out where I’d like to deploy my fresh capital in November.

As I mentioned above, there’s no shortage of sectors nor individual stocks for us to choose from when considering where to invest this month. Looking ahead to November I’m having a relatively easy time figuring out where I would like to invest as many great names have gone on sale.

Let’s start with the obvious sector that’s getting hammered as of late, the health sector. Here, I am considering adding to my current positions of Cardinal Health, Inc. (CAH) and AbbVie Inc. (ABBV). While I realize both have their investment risks, I feel that at current levels they can make great long term additions to any dividend growth portfolio. With healthy double digit raises for both CAH and ABBV announced in 2016 and better prices and values and higher yields these days both names look like good candidates for November buys.

Moving over to the finance sector I am continuing to watch beaten down Wells Fargo & Company (WFC). It looks like this stock will experience more pain in the near and mid term but further down the road I think WFC will come out ahead. As long as that dividend payout ratio is well managed, which it is, and the potential for interest rate hikes in the next year, it becomes hard to ignore a 3%+ yielding dividend machine like WFC. Also, in the finance space I am considering adding to my small position of T. Rowe Price Group, Inc. (TROW). Like many other financial names, TROW has been drifting lower the last couple of months and is now trading with an attractive current yield of 3.37% and moderate payout ratio too. These lower prices for TROW are making it look like a much better value than we saw as recent as August.